Elsevier Hematology (@elshematology) 's Twitter Profile
Elsevier Hematology

@elshematology

Research news from our Hematology journals, for scientists, students, practitioners, and industry professionals. Publishing support: bit.ly/publish_support

ID: 1934440580

linkhttp://www.hematologyadvance.com calendar_today04-10-2013 14:29:56

3,3K Tweet

8,8K Followers

616 Following

RPTH (@rpthjournal) 's Twitter Profile Photo

🦶Plantar Vein Thrombosis (PVT) is rare but often misdiagnosed. A 17 year study by Serifi et al sheds light on this condition, highlighting cancer as a key risk factor and the efficacy of therapeutic anticoagulation. More Data: rpthjournal.org/article/S2475-… Elsevier Hematology

🦶Plantar Vein Thrombosis (PVT) is rare but often misdiagnosed. A 17 year study by Serifi et al sheds light on this condition, highlighting cancer as a key risk factor and the efficacy of therapeutic anticoagulation. 
More Data: rpthjournal.org/article/S2475-…
<a href="/ELShematology/">Elsevier Hematology</a>
Thrombosis Update (@thrombupdate) 's Twitter Profile Photo

In this new Thrombosis Update review article, the authors suggest that PDPN represents an attractive putative target for therapies that aim to simultaneously reduce cancer progression and #CAT Colin E Evans 🫀🫁 Kiesha Wilson, Ph.D. 🐁🫁🧬🔬👩🏽‍🔬 Elsevier Hematology Read more here: sciencedirect.com/science/articl…

In this new <a href="/ThrombUpdate/">Thrombosis Update</a> review article, the authors suggest that PDPN represents an attractive putative target for therapies that aim to simultaneously reduce cancer progression and #CAT 
<a href="/EvansLaboratory/">Colin E Evans 🫀🫁</a> <a href="/WilsonLabUofSC/">Kiesha Wilson, Ph.D. 🐁🫁🧬🔬👩🏽‍🔬</a> <a href="/ELShematology/">Elsevier Hematology</a> 
Read more here:
sciencedirect.com/science/articl…
Keisuke Ito_Lab (@the_ito_lab) 's Twitter Profile Photo

Great chat with Grant (Grant Rowe) and Vijay (Vijay Sankaran) at Boston Children's! Thanks for discussing mitochondrial regulation in adult and developmental hematopoiesis and experimental hematology Elsevier Hematology. Excited for collaborations! See you at ISEH in Chicago!

Great chat with Grant (<a href="/bloodandtime1/">Grant Rowe</a>) and Vijay (<a href="/bloodgenes/">Vijay Sankaran</a>) at <a href="/BostonChildrens/">Boston Children's</a>! Thanks for discussing mitochondrial regulation in adult and developmental hematopoiesis and experimental hematology <a href="/ELShematology/">Elsevier Hematology</a>. Excited for collaborations! See you at <a href="/ISEHSociety/">ISEH</a> in Chicago!
Elsevier Hematology (@elshematology) 's Twitter Profile Photo

Year of the Zebra: In Review! Amplifying voices in the rare disease community taught us the power of unity, awareness, & advocacy. Together, we've highlighted crucial issues & fostered a stronger support network. Let's keep pushing for progress & hope. spkl.io/601744McB

Year of the Zebra: In Review! Amplifying voices in the rare disease community taught us the power of unity, awareness, &amp; advocacy. Together, we've highlighted crucial issues &amp; fostered a stronger support network. Let's keep pushing for progress &amp; hope. spkl.io/601744McB
Thrombosis Update (@thrombupdate) 's Twitter Profile Photo

FXI inhibitors promise to prevent thrombosis while maintaining hemostasis. In this recent review, the authors provided insights into FXI inhibitors and future perspectives. Peter Verhamme Matthias M Engelen Elsevier Hematology #ThrJournal Read more here: sciencedirect.com/science/articl…

FXI inhibitors promise to prevent thrombosis while maintaining hemostasis.
In this recent review, the authors provided insights into FXI inhibitors and future perspectives.
<a href="/VerhammePeter/">Peter Verhamme</a> <a href="/MatthiasEngelen/">Matthias M Engelen</a> <a href="/ELShematology/">Elsevier Hematology</a> 
#ThrJournal 
Read more here: sciencedirect.com/science/articl…
Thrombosis Update (@thrombupdate) 's Twitter Profile Photo

In the recent Thrombosis Update article the authors assessed the impact of anticoagulants, antiplatelet agents, and oral antidiabetic drugs on the risk of stroke in patients with diabetes/nonvalvular AF Elsevier Hematology #ThrJournal Read more here at: sciencedirect.com/science/articl…

In the recent <a href="/ThrombUpdate/">Thrombosis Update</a> article the authors assessed the impact of anticoagulants, antiplatelet agents, and oral antidiabetic drugs on the risk of stroke in patients with diabetes/nonvalvular AF
<a href="/ELShematology/">Elsevier Hematology</a> #ThrJournal
Read more here at:
sciencedirect.com/science/articl…
Elsevier Hematology (@elshematology) 's Twitter Profile Photo

Testing for the lupus anticoagulant: the good, the bad, and the ugly An article published in #RPTH. Click the link to read: spkl.io/60194fBd5

Elsevier Hematology (@elshematology) 's Twitter Profile Photo

Evaluation of thrombomodulin/TAFI function in plasma using tPA-induced plasma clot lysis time. Article in Press - #RPTH Read it now at spkl.io/60194fBdU

Evaluation of thrombomodulin/TAFI function in plasma using tPA-induced plasma clot lysis time.
Article in Press - #RPTH
Read it now at spkl.io/60194fBdU
Elsevier Hematology (@elshematology) 's Twitter Profile Photo

Identification of Heparin Interaction Sites on TAFI that Modulate Plasmin-mediated Activation, Thermal Stability and Antifibrinolytic Potential An original article published in #RPTH. Read the article here: spkl.io/60174fBdx

Identification of Heparin Interaction Sites on TAFI that Modulate Plasmin-mediated Activation, Thermal Stability and Antifibrinolytic Potential
An original article published in #RPTH. Read the article here: spkl.io/60174fBdx
Elsevier Hematology (@elshematology) 's Twitter Profile Photo

Mitral regurgitation is associated with similar loss of von Willebrand factor large multimers but lower frequency of anemia compared with aortic stenosis An original article published in #RPTH. spkl.io/60164fBdA

Elsevier Hematology (@elshematology) 's Twitter Profile Photo

Obstetric antiphospholipid syndrome carries an increased lifetime risk for obstetric and thrombotic complications—a population-based study An original article published in #RPTH. Read it here: spkl.io/60134fBeD

Elsevier Hematology (@elshematology) 's Twitter Profile Photo

#UndiagnosedHackathon2024 at Radboud University’s Experience Center in Nijmegen! With 42 patients enrolled, how many will find a diagnosis in the next 48 hours? Let’s push the limits of healthcare innovation & solve medical mysteries! spkl.io/60114foCP

#UndiagnosedHackathon2024 at Radboud University’s Experience Center in Nijmegen! With 42 patients enrolled, how many will find a diagnosis in the next 48 hours? Let’s push the limits of healthcare innovation &amp; solve medical mysteries! spkl.io/60114foCP
Elsevier Hematology (@elshematology) 's Twitter Profile Photo

#UndiagnosedHackathon2024 is happening now at Radboud University’s Experience Center in Nijmegen! Learn more about Rare, the Official Journal of Undiagnosed Diseases Network International. spkl.io/60184fU8E

#UndiagnosedHackathon2024 is happening now at Radboud University’s Experience Center in Nijmegen! Learn more about Rare, the Official Journal of Undiagnosed Diseases Network International. spkl.io/60184fU8E
Elsevier Hematology (@elshematology) 's Twitter Profile Photo

Team hard at work solving medical mysteries at #UndiagnosedHackathon2024 at Radboud University’s Experience Center in Nijmegen, the Netherlands. spkl.io/60154fQMz

Team hard at work solving medical mysteries at #UndiagnosedHackathon2024 at Radboud University’s Experience Center in Nijmegen, the Netherlands. spkl.io/60154fQMz
Elsevier Hematology (@elshematology) 's Twitter Profile Photo

Tania Simoncelli, Vice President, Science in Society at Chan Zuckerberg Initiative, speaks at #UndiagnosedHackathon2024 going on now at Radboud University’s Experience Center in Nijmegen, the Netherlands! spkl.io/60184fQOI @taniasimoncelli

Tania Simoncelli, Vice President, Science in Society at Chan Zuckerberg Initiative, speaks at #UndiagnosedHackathon2024 going on now at Radboud University’s Experience Center in Nijmegen, the Netherlands! spkl.io/60184fQOI 

@taniasimoncelli
Elsevier Hematology (@elshematology) 's Twitter Profile Photo

Wendy van Zelst-Stams, Editor-in-Chief of the new journal Rare, speaks at #UndiagnosedHackathon2024 going on now at Radboud University’s Experience Center in Nijmegen, the Netherlands! Learn more about Rare at spkl.io/60164fQng

Wendy van Zelst-Stams, Editor-in-Chief of the new journal Rare, speaks at #UndiagnosedHackathon2024 going on now at Radboud University’s Experience Center in Nijmegen, the Netherlands! Learn more about Rare at spkl.io/60164fQng
Elsevier Hematology (@elshematology) 's Twitter Profile Photo

Maximizing rare disease research impact requires economic principles. Key strategies: exploit treatment spillovers, foster collaboration, recognize genetic links, and organize scalable efforts. Essential read for advancing rare disease management in Rare: spkl.io/60104C6op

Maximizing rare disease research impact requires economic principles. Key strategies: exploit treatment spillovers, foster collaboration, recognize genetic links, and organize scalable efforts. Essential read for advancing rare disease management in Rare: spkl.io/60104C6op